FDA approves nivolumab with chemotherapy for previously untreated Hodgkin lymphoma
On March 20, 2026, the Food and Drug Administration approved nivolumab with doxorubicin, vinblastine, and…
Author ONA Editor
ONA Editor
The ONA Editor curates oncology news, views and reviews from Australia and around the world for our readers. In aggregated content, original sources will be acknowledged in the article footer.
Detection of bowel cancer marker in wastewater may offer new early warning system
Detection of a bowel cancer marker (CDH1) in wastewater may offer a new community-level early…
Engineered bacteria deliver cancer drug directly inside tumours in mice
Every year, millions of people are diagnosed with cancer globally; however, current treatments are limited…
Hidden drug reservoirs in cancer cells could explain treatment resistance
One of oncology’s biggest challenges is that the same treatment can work well for some…
Biologists identify factors that accelerate breast cancer recurrence
Scientists have identified a molecular mechanism underlying aggressive breast cancer. They found that the signals supporting…
Implantable “charging station” boosts immunotherapy
Immunotherapy has transformed cancer treatment by harnessing the body’s own immune system to fight disease.…
Universal, ready-to-use immunotherapy detects and destroys endometrial cancer
Endometrial cancer is the most common gynaecologic cancer in the United States and is one…
Blocking lipid production in healthy lung cells can reduce lung metastasis
Scientists have discovered how cancer cells can exploit healthy lung cells to support metastatic tumour growth in the lungs. In two…
Discovery about aging and cancer opens the door to better targeted treatments
Researchers have identified a protein linked to an increased risk of metastasis and recurrence in…
Researchers uncover distinct tumour “neighbourhoods”, with each cell subtype playing a specific role, in aggressive childhood brain cancer
New research published today in Nature finds that tumour cells within supratentorial ependymomas (SE) – an aggressive…